SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001739410-23-000019
Filing Date
2023-12-20
Accepted
2023-12-20 08:15:28
Documents
20
Period of Report
2023-12-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rlyb-20231220.htm   iXBRL 8-K 28391
2 EX-99.1 rlyb-122023xex991.htm EX-99.1 23084
3 EX-99.2 rlyb122023-ex992.htm EX-99.2 4399
7 rlyb122023-ex992001.jpg GRAPHIC 545277
8 rlyb122023-ex992002.jpg GRAPHIC 466611
9 rlyb122023-ex992003.jpg GRAPHIC 327733
10 rlyb122023-ex992004.jpg GRAPHIC 291122
11 rlyb122023-ex992005.jpg GRAPHIC 443935
12 rlyb122023-ex992006.jpg GRAPHIC 88106
  Complete submission text file 0001739410-23-000019.txt   3176700

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlyb-20231220.xsd EX-101.SCH 1892
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlyb-20231220_lab.xml EX-101.LAB 25850
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlyb-20231220_pre.xml EX-101.PRE 13575
14 EXTRACTED XBRL INSTANCE DOCUMENT rlyb-20231220_htm.xml XML 2917
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

IRS No.: 851083789 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40693 | Film No.: 231499418
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)